Xin Wang
23Patents
4h-index
67Co-inventors
66Inventor score
Filing activity: Aug 8, 1997 → Jul 21, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7001995B1 | Synthetic human papillomavirus genes | Chemistry; Metallurgy | 17 | Expired |
| US7211569B2 | Synthetic human papilloma virus genes | Chemistry; Metallurgy | 12 | Expired |
| US7033797B2 | Synthetic virus-like particles with heterologous epitopes | Chemistry; Metallurgy | 6 | Expired |
| US11241407B2 | Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy | Human Necessities | 4 | Active |
| US5998414A | Troponyl piperazines as dopamine D4 receptor ligands | Chemistry; Metallurgy | 3 | Expired |
| US6689366B1 | Synthetic virus like particles with heterologous epitopes | Chemistry; Metallurgy | 2 | Expired |
| US7498036B2 | Optimized expression of HPV 58 L1 in yeast | Chemistry; Metallurgy | 1 | Expired |
| US9133195B2 | Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11590168B2 | Chimeric antigen receptor comprising co-stimulatory receptor and application thereof | Chemistry; Metallurgy | 0 | Active |
| US6376225B1 | Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US10507199B2 | Molecules in the tryptophan-5-hydroxytryptophan-serotonin-NAS-melatonin/6-hydroxymelatonin sulfate-melatonin receptor 1A pathway in neurological diseases | Physics | 0 | Active |
| US7883688B2 | Polycationic polyrotaxanes capable of forming complexes with nucleic acids | Chemistry; Metallurgy | 0 | Active |
| US6867029B2 | Isolated human phosphodiesterase proteins, nucleic acid molecules encoding human phosphodiesterase proteins, and uses thereof | Chemistry; Metallurgy | 0 | Expired |
| US7976848B2 | Optimized expression of HPV 58 L1 in yeast | Chemistry; Metallurgy | 0 | Active |
| US11752133B2 | Use of bromophenol-pyrazoline compounds in the treatment of porcine coronavirus diseases | Human Necessities | 0 | Active |
| US12359169B2 | Universal CAR-T cell and preparation method and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11207425B2 | Guide RNA molecule and method for treating cancer | Chemistry; Metallurgy | 0 | Active |
| US11820763B2 | Bromophenol-pyrazoline compound and synthesis method and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11524034B2 | Chimeric antigen receptor comprising third signal receptor and use thereof | Chemistry; Metallurgy | 0 | Active |
| US6667291B2 | Method of detecting and treating cancer | Emerging Cross-Sectional Technologies | 0 | Expired |
| US11840518B2 | Use of bromophenol-pyrazoline compounds for the treatment of feline coronavirus diseases | Human Necessities | 0 | Active |
| US11827614B2 | Synthetic pathway to belzutifan and crystalline phases of synthetic intermediates | Chemistry; Metallurgy | 0 | Active |
| US11795174B2 | Anti-pain compound and preparation method thereof | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.